$0.666
-0.058 (-8.69%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de TCRX por análisis de gráficos similares
Alphio's TCRX stock price prediction model matches the current TScan Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.67 (+0.87%). The 1-week path is $0.66 (-0.77%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de TScan Therapeutics Inc?
TScan Therapeutics Inc (TCRX) is currently trading at $0.75, which is significantly lower than the analyst price target of $5, indicating potential upside. However, the stock has a low Relative Strength Index (RSI) of 38.43, suggesting it is nearing oversold conditions, but it has also seen a 56.94% decline over the past year, indicating ongoing challenges. The company reported a Q2 2026 revenue of $1.1 million, down from $3.1 million in Q2 2025, reflecting weak market demand. The main risk is the negative net income of -$30.36 million in Q2 2026, which highlights profitability concerns.
TCRX cerró en $0.67 el Tuesday, tras bajar -8.69%
TScan Therapeutics Inc (TCRX) last closed at $0.6663, losing -8.69%. These facts feed the 1-day and 1-week TCRX price prediction above.
Factores de la previsión
Los factores de la previsión de TScan Therapeutics Inc (TCRX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de TCRX, ordenadas por similitud.
Análisis de estacionalidad de TCRX
Historically the probability of a positive September return for TCRX is 9.52%. April offers the highest probability of a positive month at 64.06%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de TCRX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $0.94 | $1.46 | $1.61 | +119.34% |
| Oct 2026 | $1.26 | $1.77 | $2.18 | +165.82% |
| Nov 2026 | $1.76 | $2.10 | $2.47 | +214.84% |
| Dec 2026 | $1.62 | $2.10 | $2.70 | +214.84% |
En 2026, se proyecta que TScan Therapeutics Inc (TCRX) oscile entre $0.94 y $2.70.
Previsión mensual de TScan Therapeutics Inc para 2026
En Sep de 2026, se proyecta que TScan Therapeutics Inc promedie $1.46, con un mínimo de $0.94 y un máximo de $1.61.
En Oct de 2026, se proyecta que TScan Therapeutics Inc promedie $1.77, con un mínimo de $1.26 y un máximo de $2.18.
En Nov de 2026, se proyecta que TScan Therapeutics Inc promedie $2.10, con un mínimo de $1.76 y un máximo de $2.47.
En Dec de 2026, se proyecta que TScan Therapeutics Inc promedie $2.10, con un mínimo de $1.62 y un máximo de $2.70.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.